CEPTAVA

This brand name is authorized in Spain, Italy, United Kingdom

Active ingredients

The drug CEPTAVA contains one active pharmaceutical ingredient (API):

1 Mycophenolic acid UNII WX877SQI1G - MYCOPHENOLATE SODIUM

Mycophenolic acid is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Mycophenolic acid has more potent cytostatic effects on lymphocytes than on other cells and is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants. Read about Mycophenolic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CEPTAVA Gastro-resistant tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AA06	Mycophenolic acid	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants
Discover more medicines within L04AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 81580, 81581
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 348093, 348095
Country: IT	Agenzia del Farmaco	Identifier(s): 044778037, 044778064